NEO – neogenomics, inc. (US:NASDAQ)
Stock Stats
News
Court Grants Natera's Request to Include Additional Patent in its Lawsuit Against NeoGenomics [Yahoo! Finance]
NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Bank of America Co. from $18.00 to $19.00. They now have a "neutral" rating on the stock.
NeoGenomics' Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma [Yahoo! Finance]
NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $22.00 price target on the stock.
Form 4 NEOGENOMICS INC For: Dec 07 Filed by: Sherman Jeffrey Scott
Form 4/A NEOGENOMICS INC For: May 11 Filed by: Olivo Alicia C
Form 4/A NEOGENOMICS INC For: May 11 Filed by: Sherman Jeffrey Scott
Form 4/A NEOGENOMICS INC For: May 11 Filed by: Smith Christopher M
Form 4 NEOGENOMICS INC For: Dec 01 Filed by: Stone Warren
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.